{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","since":null,"total":15,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-10-30","event_type":"newswire_release","title":"NFL Biosciences will participate in the BIO-Europe 2026 ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261030237979/en/NFL-Biosciences-will-participate-in-the-BIO-Europe-2026-conference-to-continue-discussions-with-potential-partners-regarding-NFL-101-and-NFL-102","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"u3w9N-SWTAxOyIsqsLtVfJqvvdA1Fqna9aR_qzZPNJWAGiaezQP547ccF2T3nrkOjJAMUDnxrj1r7bJNreftDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-10-23","event_type":"results","title":"NFL Biosciences Reports Its 2026 Half-Year Results and ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261022686689/en/NFL-Biosciences-Reports-Its-2026-Half-Year-Results-and-Progress-With-Its-Two-Immunotherapies-for-Smoking-and-Nicotine-Cessation","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"KlhGUo-q-gu1hsVuHv2M2t9jzgXQcUXUPIQuvkCJNB-CSAZSFwZlPUbjE5L1pN83Z1IW8Yho9GATMiON6yPHAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-10-22","event_type":"newswire_release","title":"NFL Biosciences Receives Regulatory Approval to Begin ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261021927272/en/NFL-Biosciences-Receives-Regulatory-Approval-to-Begin-Its-Phase-2-TONIC-Trial-for-Smoking-and-Nicotine-Cessation","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"p_6ex_jbzByDtvmF532jU_jQh8Tw1c_Hll-g0k7OydhoBIzYgRsnm-z2PTvc0Y3ntEPnsUMq55fpJ20zlnSPDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-10-22","event_type":"results","title":"NFL Biosciences Reports Its 2026 Half-Year Results and ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261022686689/en/NFL-Biosciences-Reports-Its-2026-Half-Year-Results-and-Progress-With-Its-Two-Immunotherapies-for-Smoking-and-Nicotine-Cessation","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"siR8Y7U2E8xNsc9Z6PiAeZoj8c8iU0H_WADnNmJ631XgeLBqZT6cBPHoQW6dNM306Xdz5ftSNbl_9DAfnyJvAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-10-06","event_type":"newswire_release","title":"NFL Biosciences: Progress Update Ahead of Upcoming ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261005969891/en/NFL-Biosciences-Progress-Update-Ahead-of-Upcoming-Value-Creating-Milestones-for-Its-Two-Clinical-Programs-in-Smoking-Cessation","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"oZq6TNw9XuUcJ8qs9mszLtxx-Ib0BluUaKJ3ugn7ww0Js96w7YKCoKnYAXJwfHbXa8mEhFNotYDQvrjQxgzKBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-09-10","event_type":"newswire_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-tyra-biosciences-inc---tyra-302875825.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'biosciences'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4cE5UgF3NkCPyM8o7A0T6MG7oI2lkvdQYJLoTHeNPqnmQ5iHOPzDBXwfZ35Y7sWSJZWh0C1d6wbYNUKPaJByAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-04-15","event_type":"newswire_release","title":"NFL Biosciences Presents Its 2025 Annual Results and Provides an Update on Its Clinical Progress Driven by a New Paradigm in Smoking Cessation","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260415564934/en/NFL-Biosciences-Presents-Its-2025-Annual-Results-and-Provides-an-Update-on-Its-Clinical-Progress-Driven-by-a-New-Paradigm-in-Smoking-Cessation","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wRfPA1eNSl1iyhpwN1GIKzKIA6BupQxr4pqVhSjJS7907P_AbcWOPhwhW_bvS3qNX6tShqTbyRMNd8mWMeVICw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-03-11","event_type":"newswire_release","title":"Bpifrance Renews Its Confidence in NFL Biosciences Through the Granting of a €500,000 Loan","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260311333181/en/Bpifrance-Renews-Its-Confidence-in-NFL-Biosciences-Through-the-Granting-of-a-%E2%82%AC500000-Loan","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Op-ttK3Z5aNFuzAEom5le0iAdCaDHL8kPN30Bcl42ajNDN5ljXlsNqijMTb1JuRWYB8_DaBDYOsKcY9Cc7viAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-01-26","event_type":"newswire_release","title":"NFL Biosciences Significantly Raises Its Efficacy Targets for Smoking Cessation","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260126579911/en/NFL-Biosciences-Significantly-Raises-Its-Efficacy-Targets-for-Smoking-Cessation","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"p1TxFh5PED2lUbWq4V4_scGF2e0S6cgIu_tsbm5K0Dcz17aZi4u-AjUfxkHE2IEvG5FXBuxY2-RgQ32huZJiDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2026-01-01","event_type":"newswire_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-ventyx-biosciences-inc---vtyx-302650514.html","read_by":"Tavily search (wire domains) + published_date","detail":"matched on distinctive token 'biosciences'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TRhSBQnIoGVUtsZ93m31DIEIhjmh5hSlA49e6kf6kjmmveQchuh8arjB9W6ewMlyYxitfx7HtrxNgdjsKAXNAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2025-12-08","event_type":"newswire_release","title":"NFL Biosciences Obtains Complementary Characterization Results for NFL-101, its first-in-class Drug Candidate for Smoking Cessation, and Prepares a New Patent Application","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251208386019/en/NFL-Biosciences-Obtains-Complementary-Characterization-Results-for-NFL-101-its-first-in-class-Drug-Candidate-for-Smoking-Cessation-and-Prepares-a-New-Patent-Application","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"goXD7QENHF_4pTUFFUNvsX4VhiswzEYrXS7tdrwHzxJTCi0q2IqGHN62t2Kb4ZMepsmjlFssMC2ZUwq1RLu6AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2025-11-11","event_type":"newswire_release","title":"NFL Biosciences Presents the Agenda for Results Expected by Regulatory Agencies and Potential Pharmaceutical Partners","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251111593795/en/NFL-Biosciences-Presents-the-Agenda-for-Results-Expected-by-Regulatory-Agencies-and-Potential-Pharmaceutical-Partners","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XYYbp_MvPHTG9hZLaTxsleQDplbhaMooVzuW2OrjCKetHPAKrVWiJCmsC39ltShic_YVbvaWei7ce25YzqesCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2025-10-20","event_type":"newswire_release","title":"NFL Biosciences Outlines Its Development Plan for NFL-101 in Smoking Cessation Following Receipt of Scientific Advice From Several European Agencies and the U.S. FDA","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251020589598/en/NFL-Biosciences-Outlines-Its-Development-Plan-for-NFL-101-in-Smoking-Cessation-Following-Receipt-of-Scientific-Advice-From-Several-European-Agencies-and-the-U.S.-FDA","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UioQwUN3-Pzr5o2olmiwEKYeMoNUpQoA-h_E4cUDb0U4wwFr8D2RSIitfQMcIbKY8kcEvtoIhnWrMze10RCLBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2025-10-16","event_type":"results","title":"NFL Biosciences Reports Its 2025 Half-Year Results and Provides an Update on Its Development","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251016233409/en/NFL-Biosciences-Reports-Its-2025-Half-Year-Results-and-Provides-an-Update-on-Its-Development","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"f7icfjQLgHDSTgDTlR2hjFk6C7rP_EwIm2HLvrKaBNca_7eZ63DizrPkNWRPKtaVn3yJyzN4XcQO2a_-bC6lCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/ALXP/FR0014003XT0","date":"2025-10-14","event_type":"newswire_release","title":"Sagimet Biosciences Announces Participation in Three","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/10/14/3166010/0/en/Sagimet-Biosciences-Announces-Participation-in-Three-Upcoming-Investor-Conferences.html","read_by":"Tavily search (wire domains) + URL date","detail":"matched on distinctive token 'biosciences'","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9i6f3MGnuhisp1ZUnnenujm8hOHb54V2sug_Ik9DKbNbLPLheig9q-fvdbpuDtgzQRGqcQRMxZtnOGgq7lujAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}